Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maguire

Showing results (261-270 of 373) with videos related to

Pageof 38
Sort By:
Ophthalmology|May 5, 2012
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Daniel F Martin, Maureen G Maguire, et al.
Journal of Lipid Research|March 1, 1993
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotypeL J Martin, P W Connelly, D Nancoo, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 28, 2014
Stereoacuity of preschool children with and without vision disordersElise B Ciner, Gui-Shuang Ying, Marjean Taylor Kulp, et al.
Journal of Inherited Metabolic Disease|February 11, 2005
Monitoring enzyme replacement therapy in Fabry disease--role of urine globotriaosylceramideP D Whitfield, J Calvin, S Hogg, et al.
Ophthalmology|October 22, 2013
Risk factors for amblyopia in the vision in preschoolers studyMaisie Pascual, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology|April 1, 2015
Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments TrialsThomas A Ciulla, Thomas A Cuilla, Gui-Shuang Ying, et al.
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Cornea|October 15, 2020
A New Screening Questionnaire to Identify Patients With Dry Eye With a High Likelihood of Having Sjögren SyndromeVatinee Y Bunya, Maureen G Maguire, Esen K Akpek, et al.
JAMA Ophthalmology|January 31, 2020
Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical TrialDrew Scoles, Gui-Shuang Ying, Wei Pan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 1, 2025
Association of changes in optical coherence tomography metrics with changes in refractive error in patients with neovascular age-related macular degeneration in the CATTMatthew R Starr, Eric A Lovett, Rachel Israilevich, et al.
Pageof 38

Showing results (261-270 of 373) with videos related to

Sort By:
Pageof 38
Ophthalmology|May 5, 2012
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Daniel F Martin, Maureen G Maguire, et al.
Journal of Lipid Research|March 1, 1993
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotypeL J Martin, P W Connelly, D Nancoo, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 28, 2014
Stereoacuity of preschool children with and without vision disordersElise B Ciner, Gui-Shuang Ying, Marjean Taylor Kulp, et al.
Journal of Inherited Metabolic Disease|February 11, 2005
Monitoring enzyme replacement therapy in Fabry disease--role of urine globotriaosylceramideP D Whitfield, J Calvin, S Hogg, et al.
Ophthalmology|October 22, 2013
Risk factors for amblyopia in the vision in preschoolers studyMaisie Pascual, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology|April 1, 2015
Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments TrialsThomas A Ciulla, Thomas A Cuilla, Gui-Shuang Ying, et al.
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Cornea|October 15, 2020
A New Screening Questionnaire to Identify Patients With Dry Eye With a High Likelihood of Having Sjögren SyndromeVatinee Y Bunya, Maureen G Maguire, Esen K Akpek, et al.
JAMA Ophthalmology|January 31, 2020
Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical TrialDrew Scoles, Gui-Shuang Ying, Wei Pan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 1, 2025
Association of changes in optical coherence tomography metrics with changes in refractive error in patients with neovascular age-related macular degeneration in the CATTMatthew R Starr, Eric A Lovett, Rachel Israilevich, et al.
Pageof 38